Compare QGEN & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space and cyber domains. The company is in the design, development and manufacture of Advanced sensing, network computing, force protection and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue and Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designs, develops and manufactures sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision making and execution by the customers.